GIVE

The MRF at 25

In 2021, the MRF celebrates 25 years of service to the melanoma community, all made possible by your support. Ring in the new year and help us fund the future with a tax-deductible gift today.

Advocacy

2021 Advocacy Days

Register Today!

Advocacy

2021 Advocacy Days

Save the date for the largest melanoma advocacy event of the year on March 1-5, 2021! Registration for this free, virtual event opens on December 7, 2020.

Research & Science

Apply for 2021 Research Funding

Research & Science

Apply for 2021 Research Funding

The MRFBC-BMS Young Investigator Team Award Request for Proposals (RFP) is now available! Applications are accepted January 4 – March 15, 2021.

Advocacy

Congress Passes $30 Million in Defense-Funded Melanoma Research

 

Advocacy

Congress Passes $30 Million in Defense-Funded Melanoma Research

On Monday, December 21, 2020, both Houses of Congress passed the final version of the FY 2021 Department of Defense (DOD) Appropriations bill and included $30 million for melanoma research within the Congressionally Directed Medical Research Program (CDMRP). The $30 million for the Peer Reviewed Melanoma Research Program is a $10 million increase over FY 2020 appropriations.

Patients & Caregivers

COVID-19 Vaccine and Melanoma

Patients & Caregivers

COVID-19 Vaccine and Melanoma

BREAKING NEWS: SITC Recommendations for COVID-19 Vaccination & Cancer Immunotherapy.

Patients & Caregivers

NEW: Online Patient Forum

Patients & Caregivers

NEW: Online Patient Forum

Visit the newly updated and fully modern MRF Patient Forum to ask questions, seek practical advice and find support. Join the conversation today!

The MRF’s mission is to eradicate melanoma by accelerating medical RESEARCH while EDUCATING to and ADVOCATING for the melanoma community.

Melanoma is the deadliest form of skin cancer.

Melanoma claims the lives of nearly 7,000 Americans every year.

Melanoma is the leading cause of cancer death in young women ages 25 – 30 and the second leading cause of cancer death in women ages 30-35.

9 out of 10 cases are considered to be preventable.

Funding Melanoma Research

Funding from The MRF has resulted in:

clinical trials

22 Clinical trials

collaborations

83 Grants with new collaborations
publications

204 Publications

presentations

409 Presentations

Recent Funded Research Recipients

Career Development Award 2020

Zachary Schug, PhD

The Wistar Institute

Elucidating Metabolic Changes that Occur in Melanoma Brain Metastases

Established Investigator Award 2020

Thorsten Mempel, MD, PhD

Massachusetts General Hospital

Converting Regulatory into Proinflammatory Anti-Tumor Effector T Cells

Established Investigator Award 2020

Linda Malkas, PhD

Beckman Research Institute of the City of Hope

Novel Target for Melanoma Therapeutic Development

Team Award 2020

Diwakar Davar, MD

University of Pittsburgh (Mentor: Hassane Zarour, MD)

Integrative Analysis of Prognostic Factors to Neoadjuvant Nivolumab/CMP-001 in Stage III B/C/D Melanoma
VIEW ALL FUNDED RESEARCH

Latest News

shoushtari
Guest blog from Dr. Alex Shoushtari, medical oncologist with an expertise in uveal melanoma:  Getting a dilated eye exam is
Ryan wp
Guest blog from Ryan Forgach, OM survivor:  For many, including my family, my journey into learning about ocular melanoma (OM)
Vikki WP
Guest blog by Vikki McConnell, OM survivor:  Everyone tells you about your 20s. How it’s full of fun, freedom and
Steve WP
Guest blog by Steven Johnson, OM survivor:  I vividly remember the first time that I noticed some visual disturbances in
VIEW ALL NEWS

Optimize Your Treatment

Although the MRF cannot recommend a specific doctor, clinic or clinical trial, the Melanoma Treatment Center Finder and Clinical Trial Finder will help you find an experienced melanoma treatment team, as well as give you the opportunity to explore clinical trials. Did you know that clinical trials are often viewed as the best treatment option for Stage II, III and IV melanoma patients?

Please remember to use this information as a starting point in your search for a healthcare team that best meets your needs. All information regarding your treatment should be discussed with your healthcare professional.

FIND A TREATMENT CENTER       FIND A CLINICAL TRIAL

Patient
Resources

The MRF is committed to providing the most up-to-date education and support resources for melanoma patients and their loved ones.